Secondary analysis results from VAYHIT3, a phase 2 study of ianalumab in patients with primary immune thrombocytopenia previously treated with at least two lines of therapy


Choi P., Bradbury C., Gonzalez-Lopez T. J., AR M. C., Trautmann-Grill K., Rummel M., ...More

BLOOD, vol.146, pp.844-845, 2025 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Abstract
  • Volume: 146
  • Publication Date: 2025
  • Doi Number: 10.1182/blood-2025-844
  • Journal Name: BLOOD
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Chemical Abstracts Core, EMBASE, Nature Index
  • Page Numbers: pp.844-845
  • Istanbul University Affiliated: No